Ángel Juan García-Yagüe studied Biochemistry at the Autonomous University of Madrid (2006), holds a PhD in Biochemistry (2012), and since 2012 has been hired as a scientific researcher in the same university under the supervisor of the Cuadrado lab. During his professional career, he had focused at to study and understanding the neurological process that drives neurodegenerative pathology disease, on focus Parkinson’s disease, through the physiopathological mechanics study of the transcription factor NURR1. Currently, he is leading several research projects to focus on the NRF2 role in brain physiology and pathology related to blood-brain-barrier integrity, search for new NRF2 inductors, and collaborating with pharmaceutical and nutraceutical company for research about novel pharmacological approaches in preclinical models of neurodegenerative diseases.
Ángel Juan García-Yagüe studied Biochemistry at the Autonomous University of Madrid (2006), holds a PhD in Biochemistry (2012), and since 2012 has been hired as a scientific researcher in the same university under the supervisor of the Cuadrado lab. During his professional career, he had focused at to study and understanding the neurological process that drives neurodegenerative pathology disease, on focus Parkinson’s disease, through the physiopathological mechanics study of the transcription factor NURR1. Currently, he is leading several research projects to focus on the NRF2 role in brain physiology and pathology related to blood-brain-barrier integrity, search for new NRF2 inductors, and collaborating with pharmaceutical and nutraceutical company for research about novel pharmacological approaches in preclinical models of neurodegenerative diseases.